Eli Lilly ' s Rheumatoid Arthritis Drug Accelerates Recovery in COVID-19 Patients Eli Lilly ' s Rheumatoid Arthritis Drug Accelerates Recovery in COVID-19 Patients
Eli Lilly said on Monday its rheumatoid arthritis drug shortened the recovery time for hospitalized COVID-19 patients also given Gilead Sciences ' s antiviral remdesivir.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Arthritis | COVID-19 | Health | Infectious Diseases | Rheumatoid Arthritis | Rheumatology